Negative regulation of humoral immune response mediated by circulating immunoglobulin

pathway activity & survival
GO:0002924SurvivalRNA activityKaplan–Meier · TCGA cohorts

Across TCGA pan-cancer cohorts, RNA activity of the Negative regulation of humoral immune response mediated by circulating immunoglobulin pathway is associated with patient survival in 15 of 34 cancer lineages. Pathway activity is summarized from the expression of its 11 member genes.

The strongest signal is observed in lung squamous cell carcinoma (LUSC), where higher Negative regulation of humoral immune response mediated by circulating immunoglobulin pathway activity is associated with better disease-free survival. In most high-consensus cancer types, elevated pathway activity shows an unfavorable survival association, although some cancer types, such as LUSC and LUAD, show the opposite pattern, with higher activity associated with better survival.

LUSC, LUAD, and PAAD are the cancer lineages in which this pathway most reproducibly stratifies patient survival.

Pathway-activity survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 represent the survival AUCs for the high- and low-pathway-activity groups, respectively. The group with the lower AUC is interpreted as having poorer survival. The reported p-values are derived from the log-rank test.
LineageMeasureSplitStageAUC1
high
AUC2
low
pSampling consensus
LUSCDFSTertileII,III,IV0.8140.630.00159view →
LUADDFSTertileAll0.7880.592.00356view →
PAADDFSTertileAll0.4430.188.00133view →
LIHCOSQuartileAll0.8720.547.00419view →
SCLCOSTertileII,III,IV0.2670.702.00218view →
STADOSMedianIII,IV0.6980.295.00514view →
COADOSTertileIII,IV0.6520.916.00714view →
ACCOSQuartileIV0.8440.383.00611view →
SKCMOSQuartileAll0.5270.339.00510view →
BLCAOSQuartileII,III,IV0.8020.669.0189view →
MESOOSQuartileAll0.3910.247.0269view →
KICHOSMedianII,III,IV0.8601.000.0287view →
Pink = unfavorable, green = favorable. Showing the 12 strongest of 15 lineages.

GO:0002924–LUSC (DFS)

Kaplan–Meier survival curve for Negative regulation of humoral immune response mediated by circulating immunoglobulin pathway activity in LUSC.

Open the LUSC breakdown →

Exploration